Explore

Trendline Trendline
Researchers Identify Key Factors in Manufacturing Bispecific Antibodies

Researchers Identify Key Factors in Manufacturing Bispecific Antibodies

Researchers Identify Key Factors in Manufacturing Bispecific Antibodies
Trendline Trendline
Novelty Nobility Expands AGC Biologics Partnership for Antibody Manufacturing

Novelty Nobility Expands AGC Biologics Partnership for Antibody Manufacturing

Novelty Nobility Expands AGC Biologics Partnership for Antibody Manufacturing
Discover daily Discover daily
How Peptides Aim at Disease With Unusual Precision

How Peptides Aim at Disease With Unusual Precision

Peptides have emerged as a significant class of compounds in the field of medicine, offering promising therapeutic potential. These short chains of...
Trendline Trendline
Pilatus Biosciences Forms Scientific Advisory Board to Advance Cancer Therapies

Pilatus Biosciences Forms Scientific Advisory Board to Advance Cancer Therapies

Pilatus Biosciences Forms Scientific Advisory Board to Advance Cancer Therapies
Trendline Trendline
Innate Pharma Schedules Q1 2026 Business Update Conference Call

Innate Pharma Schedules Q1 2026 Business Update Conference Call

Innate Pharma Schedules Q1 2026 Business Update Conference Call
Trendline Trendline
Novelty Nobility Expands AGC Biologics Deal for GMP Manufacturing of Antibody Drug

Novelty Nobility Expands AGC Biologics Deal for GMP Manufacturing of Antibody Drug

Novelty Nobility Expands AGC Biologics Deal for GMP Manufacturing of Antibody Drug
Trendline Trendline
Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy

Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy

Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy
Trendline Trendline
MilliporeSigma Expands Temecula Site, Enhancing Biotech Manufacturing Capabilities

MilliporeSigma Expands Temecula Site, Enhancing Biotech Manufacturing Capabilities

MilliporeSigma Expands Temecula Site, Enhancing Biotech Manufacturing Capabilities
Trendline Trendline
Alloy Therapeutics and IPI Collaborate to Enhance Antibody Discovery

Alloy Therapeutics and IPI Collaborate to Enhance Antibody Discovery

Alloy Therapeutics and IPI Collaborate to Enhance Antibody Discovery
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations
Trendline Trendline
Armatus Bio Develops Scalable Potency Assay Platform for Gene Silencing Therapies

Armatus Bio Develops Scalable Potency Assay Platform for Gene Silencing Therapies

Armatus Bio Develops Scalable Potency Assay Platform for Gene Silencing Therapies
Trendline Trendline
Pharmaceutical Industry Utilizes Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Industry Utilizes Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Industry Utilizes Protein Biomarkers to Mitigate Drug Development Risks